US Stock MarketDetailed Quotes

Carisma Therapeutics (CARM)

Watchlist
  • 0.0464
  • +0.0017+3.69%
15min DelayClose Jan 22 15:39 ET
1.94MMarket Cap-0.04P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Carisma Therapeutics (CARM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
1,236.78%45.25M
0
9.77%3.73M
31.59%19.63M
-14.83%3.65M
-11.55%3.39M
158.34%9.2M
4.75%3.4M
51.71%14.92M
14.96%4.29M
Operating revenue
1,236.78%45.25M
--0
9.77%3.73M
31.59%19.63M
-14.83%3.65M
-11.55%3.39M
158.34%9.2M
4.75%3.4M
51.71%14.92M
14.96%4.29M
Cost of revenue
Gross profit
Operating expense
-91.31%1.44M
-72.31%5.78M
-42.97%13.06M
-21.07%81.81M
-19.56%21.51M
-36.84%16.53M
-14.92%20.87M
-12.62%22.91M
57.05%103.65M
40.34%26.74M
Selling and administrative expenses
-76.19%1.24M
-39.68%3.35M
-28.25%3.91M
-25.02%22.14M
-19.03%5.93M
-21.40%5.2M
-7.44%5.56M
-43.13%5.45M
214.83%29.53M
654.27%7.32M
-General and administrative expense
-76.19%1.24M
-39.68%3.35M
-28.25%3.91M
-25.02%22.14M
-19.03%5.93M
-21.40%5.2M
-7.44%5.56M
-43.13%5.45M
214.83%29.53M
654.27%7.32M
Research and development costs
-98.26%197K
-84.16%2.42M
-47.57%9.16M
-19.50%59.67M
-19.76%15.58M
-42.07%11.33M
-17.34%15.31M
4.93%17.46M
30.92%74.13M
7.37%19.42M
Operating profit
433.34%43.81M
50.49%-5.78M
52.16%-9.33M
29.92%-62.18M
20.47%-17.86M
41.17%-13.14M
44.34%-11.67M
15.07%-19.51M
-57.99%-88.73M
-46.52%-22.45M
Net non-operating interest income expense
-87.22%68K
-12.09%1.7M
-83.01%220K
-53.03%442K
-56.84%508K
136.02%532K
161.56%1.94M
249.37%1.3M
Non-operating interest income
----
----
----
-12.09%1.7M
----
----
----
----
--1.94M
----
Total other finance cost
----
----
87.22%-68K
----
----
53.03%-442K
56.84%-508K
-136.02%-532K
----
----
Other net income (expense)
104.30%903K
-886.61%-4M
442K
508K
95.62%-84K
0
Gain on sale of security
----
----
----
----
----
----
----
----
95.62%-84K
--0
Special income (charges)
--320K
---4.47M
----
----
----
--0
--0
----
----
----
-Less:Impairment of capital assets
--0
--927K
----
----
----
--0
--0
----
----
----
-Gain on sale of property,plant,equipment
--320K
---3.54M
----
----
----
--0
--0
----
----
----
Other non- operating income (expenses)
31.90%583K
-7.48%470K
----
----
----
--442K
--508K
----
----
----
Income before tax
452.05%44.72M
12.44%-9.77M
51.18%-9.27M
30.39%-60.48M
16.64%-17.64M
40.65%-12.7M
43.59%-11.16M
22.64%-18.98M
-41.90%-86.88M
-26.38%-21.16M
Income tax
0
0
0
0
0
0
Net income
452.05%44.72M
12.44%-9.77M
51.18%-9.27M
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
Net income continuous Operations
452.05%44.72M
12.44%-9.77M
51.18%-9.27M
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
Minority interest income
Net income attributable to the parent company
452.05%44.72M
12.44%-9.77M
51.18%-9.27M
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
452.05%44.72M
12.44%-9.77M
51.18%-9.27M
30.39%-60.48M
15.86%-17.64M
40.65%-12.7M
43.84%-11.16M
22.99%-18.98M
-41.90%-86.88M
-25.20%-20.96M
Basic earnings per share
445.16%1.07
14.81%-0.23
52.17%-0.22
43.63%-1.46
12.50%-0.42
41.51%-0.31
44.90%-0.27
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
Diluted earnings per share
445.16%1.07
14.81%-0.23
52.17%-0.22
43.63%-1.46
12.50%-0.42
41.51%-0.31
44.90%-0.27
76.17%-0.46
-70.29%-2.59
-15.43%-0.48
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 1,236.78%45.25M09.77%3.73M31.59%19.63M-14.83%3.65M-11.55%3.39M158.34%9.2M4.75%3.4M51.71%14.92M14.96%4.29M
Operating revenue 1,236.78%45.25M--09.77%3.73M31.59%19.63M-14.83%3.65M-11.55%3.39M158.34%9.2M4.75%3.4M51.71%14.92M14.96%4.29M
Cost of revenue
Gross profit
Operating expense -91.31%1.44M-72.31%5.78M-42.97%13.06M-21.07%81.81M-19.56%21.51M-36.84%16.53M-14.92%20.87M-12.62%22.91M57.05%103.65M40.34%26.74M
Selling and administrative expenses -76.19%1.24M-39.68%3.35M-28.25%3.91M-25.02%22.14M-19.03%5.93M-21.40%5.2M-7.44%5.56M-43.13%5.45M214.83%29.53M654.27%7.32M
-General and administrative expense -76.19%1.24M-39.68%3.35M-28.25%3.91M-25.02%22.14M-19.03%5.93M-21.40%5.2M-7.44%5.56M-43.13%5.45M214.83%29.53M654.27%7.32M
Research and development costs -98.26%197K-84.16%2.42M-47.57%9.16M-19.50%59.67M-19.76%15.58M-42.07%11.33M-17.34%15.31M4.93%17.46M30.92%74.13M7.37%19.42M
Operating profit 433.34%43.81M50.49%-5.78M52.16%-9.33M29.92%-62.18M20.47%-17.86M41.17%-13.14M44.34%-11.67M15.07%-19.51M-57.99%-88.73M-46.52%-22.45M
Net non-operating interest income expense -87.22%68K-12.09%1.7M-83.01%220K-53.03%442K-56.84%508K136.02%532K161.56%1.94M249.37%1.3M
Non-operating interest income -------------12.09%1.7M------------------1.94M----
Total other finance cost --------87.22%-68K--------53.03%-442K56.84%-508K-136.02%-532K--------
Other net income (expense) 104.30%903K-886.61%-4M442K508K95.62%-84K0
Gain on sale of security --------------------------------95.62%-84K--0
Special income (charges) --320K---4.47M--------------0--0------------
-Less:Impairment of capital assets --0--927K--------------0--0------------
-Gain on sale of property,plant,equipment --320K---3.54M--------------0--0------------
Other non- operating income (expenses) 31.90%583K-7.48%470K--------------442K--508K------------
Income before tax 452.05%44.72M12.44%-9.77M51.18%-9.27M30.39%-60.48M16.64%-17.64M40.65%-12.7M43.59%-11.16M22.64%-18.98M-41.90%-86.88M-26.38%-21.16M
Income tax 000000
Net income 452.05%44.72M12.44%-9.77M51.18%-9.27M30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M
Net income continuous Operations 452.05%44.72M12.44%-9.77M51.18%-9.27M30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M
Minority interest income
Net income attributable to the parent company 452.05%44.72M12.44%-9.77M51.18%-9.27M30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 452.05%44.72M12.44%-9.77M51.18%-9.27M30.39%-60.48M15.86%-17.64M40.65%-12.7M43.84%-11.16M22.99%-18.98M-41.90%-86.88M-25.20%-20.96M
Basic earnings per share 445.16%1.0714.81%-0.2352.17%-0.2243.63%-1.4612.50%-0.4241.51%-0.3144.90%-0.2776.17%-0.46-70.29%-2.59-15.43%-0.48
Diluted earnings per share 445.16%1.0714.81%-0.2352.17%-0.2243.63%-1.4612.50%-0.4241.51%-0.3144.90%-0.2776.17%-0.46-70.29%-2.59-15.43%-0.48
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -